The first case of resistance to Tamiflu, considered to be the most effective treatment for swine flu by the World Health Organisation, has been reported in Denmark.
A patient who had been in direct contact with a person suffering from the new H1N1 influenza strain was given a dose of Tamiflu as a preventative measure.
But she still contracted the virus after her body resisted the treatment leading doctors to give her another type of medication, Relenza, made by GlaxoSmithKline, the British pharmaceutical company.
The Danish national is no longer suffering from the illness and is not displaying symptoms, the Danish Institute of Serology said in a statement......
BTA Price at posting:
$1.23 Sentiment: LT Buy Disclosure: Held
